OrbiMed’s Outset Medical OM Stock Holding History

OrbiMed’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,333	Closed	-$7.11M	–	173
2020 Q4	$7.11M	Hold	8,333	–	–	0.06%	134
2020 Q3	$6.25M	Buy	+8,333	New	+$6.84M	0.08%	122

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed's OM Position: Q1 2021 in Review

OrbiMed sold out of Outset Medical (OM) in Q1 2021, closing a stake of 8,333 shares — an estimated $7.11M sold.

OrbiMed first reported a position in OM in Q3 2020 and held it in 2 quarters. The position peaked at $7.11M in Q4 2020. 111 funds tracked by Wall St. Rank hold OM as of Q1 2021.

OrbiMed reported no remaining Outset Medical position as of Q1 2021 after selling out during the quarter.
OrbiMed sold 8,333 Outset Medical shares in Q1 2021, an estimated $7.11M.
OrbiMed first reported a position in Outset Medical in Q3 2020 and held it in 2 quarters.
OrbiMed's Outset Medical position peaked at $7.11M in Q4 2020.
111 funds tracked by Wall St. Rank held Outset Medical as of Q1 2021.

Based on OrbiMed's 13F filing for Q1 2021, filed 17 May 2021.